how much do glp 1 pills cost Understanding the Real of GLP-1 Medications Taking GLP-1s once meant injecting

Retatrutide does not hold MHRA marketing authorisation and is not licensed for use in the UK outside of regulated clinical trials

Clinicians aim for the lowest dose that still helps regulate appetite and stabilize weight

Therefore, GLP-1 medications mimic and enhance the natural physiology of the body

The most significant clinical data for retatrutide to date comes from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)

Int J Mol Sci 2024;25

Conversely, Europe exhibits substantial growth potential, supported by robust healthcare systems, heightened awareness of chronic diseases, and the availability of novel therapies